81 related articles for article (PubMed ID: 3101070)
1. Overcoming mitomycin C resistance with semisynthetic derivatives.
Brattain MG; Willson JK; Long BH; Chakrabarty S; Yeoman LC; Stringfellow DA
Prog Clin Biol Res; 1986; 223():63-79. PubMed ID: 3101070
[No Abstract] [Full Text] [Related]
2. Effects of BMY 25282, a mitomycin C analogue, in mitomycin C-resistant human colon cancer cells.
Willson JK; Long BH; Chakrabarty S; Brattain DE; Brattain MG
Cancer Res; 1985 Nov; 45(11 Pt 1):5281-6. PubMed ID: 3931904
[TBL] [Abstract][Full Text] [Related]
3. Circumvention of deficient activation in mitomycin C-resistant human colonic carcinoma cells by the mitomycin C analogue BMY25282.
Chakrabarty S; Danels YJ; Long BH; Willson JK; Brattain MG
Cancer Res; 1986 Jul; 46(7):3456-8. PubMed ID: 3754788
[TBL] [Abstract][Full Text] [Related]
4. Mitomycin C resistance in a human colon carcinoma cell line associated with cell surface protein alterations.
Willson JK; Long BH; Marks ME; Brattain DE; Wiley JE; Brattain MG
Cancer Res; 1984 Dec; 44(12 Pt 1):5880-5. PubMed ID: 6437674
[TBL] [Abstract][Full Text] [Related]
5. Occurrence of cytosolic protein and phosphoprotein changes in human colon tumor cells with the development of resistance to mitomycin C.
Taylor CW; Brattain MG; Yeoman LC
Cancer Res; 1985 Sep; 45(9):4422-7. PubMed ID: 3928156
[TBL] [Abstract][Full Text] [Related]
6. Effects of mitomycin on human colon carcinoma cells.
Long BH; Willson JK; Brattain DE; Musial S; Brattain MG
J Natl Cancer Inst; 1984 Oct; 73(4):787-92. PubMed ID: 6434780
[TBL] [Abstract][Full Text] [Related]
7. [Recent advanced studies on mitomycins, antitumor activity and mode of action].
Taguchi T; Morimoto M
Gan To Kagaku Ryoho; 1987 Jul; 14(7):2396-409. PubMed ID: 3111386
[TBL] [Abstract][Full Text] [Related]
8. [Effect of mitomycin C on human gastric and colon carcinomas serially transplanted to nude mice--with special reference to the start of drug administration].
Kubota T; Hanatani Y; Tsuyuki K; Nakada M; Asanuma F; Ishibiki K; Abe O
Gan To Kagaku Ryoho; 1982 Apr; 9(4):638-45. PubMed ID: 6820902
[TBL] [Abstract][Full Text] [Related]
9. [Fluctuations of cancer tissue cell proteins determined by two-dimensional electrophoresis before and after antineoplastic agent administration--indices of the efficacy of antineoplastic agents].
Takahashi T; Takami H; Sadahiro S; Okuda Y; Kodaira S
Gan To Kagaku Ryoho; 1985 May; 12(5):1158-9. PubMed ID: 3922315
[No Abstract] [Full Text] [Related]
10. [Effect of combination of UFT and MMC (UFT-M therapy) on human colonic cancer xenotransplanted into nude mice].
Takahashi Y; Kikuchi R; Ueno M; Mai M
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1345-7. PubMed ID: 3107480
[No Abstract] [Full Text] [Related]
11. Experimental and clinical activity of mitomycin C and cis-diamminedichloroplatinum in malignant mesothelioma.
Chahinian AP; Norton L; Holland JF; Szrajer L; Hart RD
Cancer Res; 1984 Apr; 44(4):1688-92. PubMed ID: 6423278
[TBL] [Abstract][Full Text] [Related]
12. pH dependence of mitomycin C-induced cross-linking activity in EMT6 tumor cells.
Kennedy KA; McGurl JD; Leondaridis L; Alabaster O
Cancer Res; 1985 Aug; 45(8):3541-7. PubMed ID: 3926302
[TBL] [Abstract][Full Text] [Related]
13. [Assessment of the combined effects of mitomycin C with alpha-interferon or gamma-interferon by the clonogenic assay technique].
Hirabayshi N; Nishiyama M; Yamaguchi M; Yoshinaka K; Nosoh Y; Toge T; Niimoto M; Hattori T; Ohkita T
Gan To Kagaku Ryoho; 1985 May; 12(5):1056-62. PubMed ID: 3922307
[TBL] [Abstract][Full Text] [Related]
14. [Anticancer activities of a new mitomycin derivative KW 2149, against human tumors xenografted into nude mice].
Nishiyama M; Kim R; Saeki T; Takagami S; Kirihara Y; Jinushi K; Toge T; Niimoto M; Hattori T
Gan To Kagaku Ryoho; 1988 Nov; 15(11):3133-7. PubMed ID: 3142368
[TBL] [Abstract][Full Text] [Related]
15. Hyperthermic enhancement of cell killing by mitomycin C in mitomycin C-resistant Chinese hamster ovary cells.
Wallner KE; Banda M; Li GC
Cancer Res; 1987 Mar; 47(5):1308-12. PubMed ID: 3102043
[TBL] [Abstract][Full Text] [Related]
16. Enzymatic and pH modulation of mitomycin C-induced DNA damage in mitomycin C-resistant HCT 116 human colon cancer cells.
Pan SS; Yu F; Hipsher C
Mol Pharmacol; 1993 Jun; 43(6):870-7. PubMed ID: 8316219
[TBL] [Abstract][Full Text] [Related]
17. [Effect of UFTM therapy on primary and metastatic colon cancer of human xenotransplanted in nude mice].
Takahashi Y; Ohta T; Mai M
Gan To Kagaku Ryoho; 1988 Sep; 15(9):2815-7. PubMed ID: 3137893
[No Abstract] [Full Text] [Related]
18. Antitumor activity of hexamethylmelamine on human tumor xenografts serially transplanted in nude mice.
Kubota T; Tanino H; Watanabe M; Kitajima M
Anticancer Res; 1994; 14(6B):2521-4. PubMed ID: 7872676
[TBL] [Abstract][Full Text] [Related]
19. Enhanced antitumor activity of irofulven in combination with thiotepa or mitomycin C.
Kelner MJ; McMorris TC; Rojas RJ; Trani NA; Estes L
Cancer Chemother Pharmacol; 2002 May; 49(5):412-8. PubMed ID: 11976836
[TBL] [Abstract][Full Text] [Related]
20. Preferential activation of mitomycin C to cytotoxic metabolites by hypoxic tumor cells.
Kennedy KA; Rockwell S; Sartorelli AC
Cancer Res; 1980 Jul; 40(7):2356-60. PubMed ID: 7388797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
